Sign in
Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages
Journal article   Open access  Peer reviewed

Type-I interferon signaling through ISGF3 complex is required for sustained Rip3 activation and necroptosis in macrophages

Scott McComb, Erin Cessford, Norah A Alturki, Julie Joseph, Bojan Shutinoski, Justyna B Startek, Ana M Gamero, Karen L Mossman and Subash Sad
Proceedings of the National Academy of Sciences - PNAS, Vol.111(31), pp.E3206-11237
05/08/2014
PMCID: PMC4128105
PMID: 25049377

Abstract

Animals Apoptosis - drug effects Enzyme Activation - drug effects Inflammation Interferon Type I - metabolism Interferon-Stimulated Gene Factor 3, gamma Subunit - metabolism Lipopolysaccharides - pharmacology Macrophages - drug effects Macrophages - metabolism Macrophages - pathology Mice Mice, Inbred C57BL Models, Biological Necrosis Oligopeptides - pharmacology Poly I-C - pharmacology Receptor, Interferon alpha-beta - deficiency Receptor, Interferon alpha-beta - metabolism Receptor-Interacting Protein Serine-Threonine Kinases - deficiency Receptor-Interacting Protein Serine-Threonine Kinases - metabolism Signal Transduction - drug effects Tumor Necrosis Factor-alpha - pharmacology
url
https://doi.org/10.1073/pnas.1407068111View
Published (Version of record) Open

Metrics

1 Record Views

Details